Renal Vascular Fibromuscular Dysplasia

2014 ◽  
pp. 23-37
Author(s):  
Barbara Ann Greco
Author(s):  
William G. Herrington ◽  
Aron Chakera ◽  
Christopher A. O’Callaghan

Renal vascular disease typically occurs with progressive narrowing of the main renal artery or smaller arterial vessels. Often, both patterns of disease coexist and result in ‘ischaemic nephropathy’ with damage to renal tissue. Much less commonly, inflammatory vasculitis can affect small or medium vessels. Ninety per cent of renal vascular disease is caused by atherosclerosis. Patients with renal vascular disease have an increased risk of cardiovascular death from associated cerebrovascular and coronary heart disease. Less than 10% of renal vascular disease is caused by fibromuscular dysplasia. The cause is unknown, but smoking is a risk factor. The disease is often bilateral and multifocal. It tends to affect the mid-portion of the renal artery, while atherosclerosis tends to occur at points of stress, especially at the junction of renal arteries with the aorta. This chapter reviews the diagnosis and management of renal vascular disease.


2021 ◽  
Vol 14 (5) ◽  
pp. e237759
Author(s):  
Aruna Munasinghe ◽  
Lilantha Wedisinghe ◽  
Thin Han ◽  
Rajit Narayan

Renal vascular hypertension is a diagnosis that needs to be entertained in the setting of refractory, otherwise unexplained hypertension in pregnancy. Conclusive diagnosis of the condition is made by the use of angiography, which confers only a low, safe dose of radiation to the fetus, especially after the first trimester. Percutaneous angioplasty is effective in treating this condition and is best performed postnatally to avoid fetal exposure to ionising radiation. While it could be managed pharmacologically, more refractory cases in pregnancy may be offered interventional treatment.


1994 ◽  
Vol 162 (3) ◽  
pp. 732-732
Author(s):  
Y Korogi ◽  
T Hirai ◽  
M Takahashi ◽  
T Sato

1979 ◽  
Vol 13 (5) ◽  
pp. 349-352 ◽  
Author(s):  
Charles A. Andersen ◽  
George J. Collins ◽  
Norman M. Rich ◽  
Paul T. Mcdonald

1987 ◽  
Vol 38 (4) ◽  
pp. 427-429 ◽  
Author(s):  
R.A. Manns ◽  
K.K. Nanda ◽  
G. Mackie

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Shuntaro Oribe ◽  
Takafumi Toyohara ◽  
Eikan Mishima ◽  
Takehiro Suzuki ◽  
Koichi Kikuchi ◽  
...  

Abstract Background Fibromuscular dysplasia (FMD) often causes renal artery stenosis with renovascular hypertension. Recent clinical outcomes encourage percutaneous transluminal renal angioplasty (PTRA) to treat FMD; however, the necessary follow-up period remains unclear. Moreover, previous studies have not revealed the difference in the period until recurrence between two major types of FMD—multifocal and focal. Case presentation We describe two patients with multifocal FMD who developed hypertension during their teenage years and had recurrence of FMD > 10 years after PTRA. We further examined the types of FMD and age of onset in 26 patients who underwent PTRA. The period until recurrence of multifocal FMD was longer than that of focal FMD. Moreover, patients with early-onset multifocal FMD are likely to have a delayed recurrence after PTRA compared to other types. Conclusions Our report suggests that patients with multifocal FMD, especially those with onset at an early age, may need long-term follow-up for at least ≥ 10 years.


Author(s):  
Manjunath G. Raju ◽  
Christopher T. Bajzer ◽  
Daniel G. Clair ◽  
Esther S.H. Kim ◽  
Heather L. Gornik

Sign in / Sign up

Export Citation Format

Share Document